Nature Reviews Disease Primers 5, Article number: 20 (2019) https://doi.org/10.1038/s41572-019-0071-6 Published online 21 March 2019
In the originally published version of Figure 1, the date for the regulatory approval of long-acting octreotide was incorrectly stated as 2004, whereas the correct date is 1998. The corrected figure has now been added to the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Colao, A., Grasso, L.F.S., Giustina, A. et al. Author Correction: Acromegaly. Nat Rev Dis Primers 5, 72 (2019). https://doi.org/10.1038/s41572-019-0129-5
Published:
DOI: https://doi.org/10.1038/s41572-019-0129-5
This article is cited by
-
Acromegaly with congenital generalized lipodystrophy – two rare insulin resistance conditions in one patient: a case report
Journal of Medical Case Reports (2020)
-
Multidisciplinary management of acromegaly: A consensus
Reviews in Endocrine and Metabolic Disorders (2020)
